| | Health Literacy: An Overlooked Factor in Understanding HIV Health DisparitiesBackgroundLimited health literacy may be a contributing factor to racial disparities in health care. This study examined the mediating effect of limited health literacy on the relationship between race and HIV-medication adherence. MethodsA total of 204 patients infected with HIV were recruited from two clinics in 2001. Structured in-person interviews were conducted to obtain information on patient demographics, medication adherence, and health literacy. Multivariate regression models were run in 2006 to examine the associations among race, literacy, and HIV-medication adherence after adjusting for relevant covariates. ResultsIn an adjusted analysis that excluded literacy, African Americans were 2.40 times more likely to be nonadherent to their HIV-medication regimen than whites (95% confidence interval [CI]=1.14–5.08). When literacy was included in the final model, the effect estimates of race diminished 25% to nonsignificance. Literacy remained a significant independent predictor of nonadherence (adjusted odds ratio [AOR]=2.12, 95% CI=1.93–2.32). ConclusionsIn this study, limited health literacy mediated the relationship between race and HIV-medication adherence. Investigators need to consider the potential utility of responding to literacy and communication barriers in health care as part of interventions to reduce racial disparities. Introduction  Recent studies have suggested that limited literacy in adults may contribute to racial disparities in health.1, 2, 3 This is important, as reducing disparities in health care is one of the two primary federal goals for public health in the United States.4, 5 According to the Institute of Medicine (IOM), 90 million people in the U.S. lack the literacy proficiency needed to properly understand and act on health information.6 This has often been referred to as health literacy, a reflection of both a patient’s ability and the literacy prerequisites of the healthcare system.7 Although limited health literacy has been associated with poorer health outcomes, and also has been shown to be more prevalent among African Americans than whites,1, 2, 3, 8, 9 it is unclear whether racial differences in health literacy explain the presence of health disparities. In the context of HIV, individuals with low literacy skills have been more likely to possess a poor working knowledge of their disease and its treatment.10, 11, 12, 13, 14, 15 Kalichman et al. 10, 11 found that infected patients with limited literacy had less general knowledge of the disease and their own treatment compared to patients with adequate literacy, and that they were less likely to have an undetectable viral load. While Paasche-Orlow et al.16 found no association between health literacy and HIV-medication adherence or viral load suppression, Wolf et al.15 found that patients with low literacy were more than three times as likely to be nonadherent to their anti-retroviral regimens than those with adequate literacy. The HIV literature also documents substantial racial disparities in health outcomes. Most noteworthy, African Americans with HIV infection are at greater risk for a faster progression to AIDS and shorter survival in comparison to whites.17, 18 Racial differences in medication usage contribute to disparities in health outcomes.19, 20, 21 Possible explanatory factors have been offered, including variability in access to medication22, 23 and adherence practices.6, 24 Although health literacy and race are independently associated with medication adherence,25 it is unclear to what extent health literacy might be an underlying mechanism that promulgates racial differences in HIV-medication adherence. Recent studies have suggested that health literacy is a more powerful predictor of health status than race.1, 2, 3 What has yet to be presented are mediating analyses exploring health literacy as a determinant of racial differences in the performance of health-promoting behaviors, such as medication adherence. As such, the objective of this study was to examine the mediating effect of health literacy on the relationship between race and HIV medication adherence. Methods  Sample The study sample and methods have been described previously in detail.13 From June to September 2001, a total of 204 consecutive HIV-infected patients on one or more antiretroviral medications were recruited from outpatient infectious disease clinics at the Northwestern Memorial Hospital (Chicago site) and the Louisiana State University Health Sciences Center at Shreveport (LSUHSC). Patients who had been on their current regimen for less than 2 weeks were excluded from participation, as were those with one or more of the following conditions, as noted in the medical record: (1) dementia, (2) blindness or severely impaired vision not correctable with eyeglasses, (3) deafness or hearing problems uncorrectable with a hearing aid, and/or (4) too ill to participate in the survey. Approval for human subjects research was obtained from institutional review boards at both study sites prior to consenting patients to the study. Data and Procedure Trained research assistants received referrals of interested and eligible patients from clinic health providers, then engaged in an informed consent process and conducted a structured interview with recruited patients. All interviews were conducted in a private room at each respective clinic immediately prior to the patients’ scheduled physician visits. Information gathered pertained to patient demographic information, medication adherence, and health literacy. Demographic questions specifically included patient age, gender, race, level of educational attainment, employment status, monthly income, and health insurance coverage. Medication Adherence Patient anti-retroviral agents, as well as comorbidities and non-HIV prescriptions, were obtained through medical chart reviews. Patients reported any recent missed doses using pages that contained the names and color photographs of common HIV medications included in a revised version of the Patient Medication Adherence Questionnaire (PMAQ).26, 27 The PMAQ requires patients to identify their medication and then report on a missed dose in the past 4 days for each anti-retroviral agent. Specifically, four questions were asked regarding whether the patient had missed taking a dose yesterday, the day before yesterday, 3 days ago, and over the past weekend. Patients were rated as having proper adherence if they reported no missed doses in this time period, while those acknowledging one or more missed doses within this short timeframe were considered nonadherent. Health Literacy Patients were asked to read aloud as many words as they could from a word-recognition list composed of 66 health-related words, Rapid Estimate of Adult Literacy in Medicine (REALM), that were arranged in order of increasing difficulty.28, 29, 30 Scores were based on the total number of words pronounced correctly, with standard English pronunciation being the scoring standard. Correct pronunciation of 0–18 words corresponded to a reading level of third grade or less, and correct pronunciation of 19–44 words corresponded to a fourth- to sixth-grade reading level. Patients who scored from 0 to 44 were considered to have low literacy. Correct pronunciation of 45–60 words indicated a seventh- or eighth-grade reading level, and patients scoring in this level were considered to have marginal literacy. Correct pronunciation of 61–66 words indicated a reading level at the ninth grade or above, and individuals with scores in this range were considered to have adequate literacy. Data Analysis All analyses were performed in 2006 (Stata version 9). Chi-square and Student’s t-tests were used to evaluate the associations among race, literacy, self-reported missed medication doses, and other sociodemographic characteristics. Patient literacy was classified as adequate (9th grade and higher), marginal (7th–8th grade), and low (6th grade and below). Race was entered as African-American or other. Multivariate regression models were used to analyze the mediational effect of literacy on racial disparities in HIV-medication adherence.31 Mediating variables were those thought to lie in a causal pathway between the main predictor variable and the outcome. First, the independent relationship between race and medication adherence was established after adjusting for exogenous covariates (gender, age, income, number of medications in regimen, and non-HIV comorbid condition) and potential interaction effects (Model 1). Education, insurance, and employment were not included in the multivariate model due to colinearity with either literacy or other socioeconomic variables in the model. Due to the low prevalence of drug and alcohol abuse (self-report of treatment in past 6 months), this variable also was not included. Second, the relationship between literacy and HIV adherence was to be tested, which had already been demonstrated and confirmed in a prior study using this same cohort.15 Finally, literacy was added to Model 1 as a mediator, and changes in odds ratios for race were analyzed (Model 2). This approach has been used by others to study the degree to which health behaviors mediate the effect of socioeconomic status on health.32 Model calibration and discrimination were estimated using the Hosmer–Lemeshow goodness-of-fit chi-square test and the C statistic from receiver operating characteristic (ROC) curves. Results  Respondents had a mean age of 40.1 years (SD=9.2 years), 79.9% were male and 45.1% were African American. More than half (55.9%) of respondents were unemployed, 39.7% had an annual household income less than $10,000, and 52.9% were either covered by Medicaid or did not carry any health insurance. Over 60% reported at least some college education. Approximately one third had either low or marginal literacy skills; 11.3% were reading at or below a 6th-grade level (low literacy), and 20.1% were reading at a 7th- to 8th-grade level (marginal literacy). More than half (52.5%) of all patients were also receiving treatment for a non–HIV-related chronic illness. Nearly one third reported receiving mental health services, and 9.3% had received treatment for alcohol or illicit drug use in the past 6 months. Over 70% were taking three or more HIV medications. Demographic and clinical characteristics are shown in Table 1. | | |  | Variable | Percentage |  |
|---|
 | Race | |  |  | Black | 45.1 |  |  | Gender | |  |  | Male | 79.9 |  |  | Age group | |  |  | <40 | 58.8 |  |  | 40–49 | 28.4 |  |  | ≥50 | 12.6 |  |  | Education | |  |  | <High school | 12.3 |  |  | High school graduate | 26.0 |  |  | >High school | 61.8 |  |  | Literacy level | |  |  | ≤6th grade (Low) | 11.3 |  |  | 7th–8th grade (Marginal) | 20.1 |  |  | ≥9th grade (Adequate) | 68.6 |  |  | Annual income | |  |  | <$10,000 | 39.7 |  |  | $10,000–$11,999 | 23.0 |  |  | $12,000–$17,999 | 9.8 |  |  | ≥$18,000 | 27.5 |  |  | Insurance | |  |  | Private | 27.5 |  |  | Medicare | 19.6 |  |  | Medicaid or free care | 52.9 |  |  | Employment | |  |  | Unemployed | 55.9 |  |  | Employed, part-time | 15.2 |  |  | Employed, full-time | 28.9 |  |  | Number of HIV medications in regimen | |  |  | 1–2 medicines | 29.9 |  |  | ≥3 medicines | 70.1 |  |  | Non-HIV comorbid conditions | |  |  | ≥1 non-HIV comorbid conditions | 52.5 |  |  | Mental illness | |  |  | Treated in past 6 months | 29.9 |  |  | Drug or alcohol abuse | |  |  | Treated in past 6 months | 9.3 |  | | | |
African-American patients were more likely to possess marginal or low literacy skills compared to non–African-American patients (52.1% vs 14.3%, p<0.001), and were significantly less likely to self-report adherence to their medication regimens in the past 4 days (60.1% vs 76.8%, p=0.014). Patients with low literacy were more likely to be nonadherent (52.2%) than patients with adequate literacy (30.0%, p=0.01). To confirm the association between race and the potential mediating variable (literacy), a preliminary regression model was analyzed with African-American race as the independent variable and low literacy skills as the dependent variable, controlling for age and study site. A significant association between African-American race and low literacy was confirmed (adjusted odds ratio [AOR]=7.4, 95% confidence interval [CI]=1.49–10.9). For Model 1 examining race and medication adherence, African Americans were 2.40 (95% CI=1.14–5.08; C statistic=0.67) times more likely to be nonadherent to their HIV-medication regimen than non–African Americans (Table 2). As illustrated in Table 2, when literacy was included in the second model, the effect estimates of African-American race diminished by 25% to a point of nonsignificance (AOR=1.80, 95% CI=0.51–5.85; C statistic=0.72). Low literacy remained a significant independent predictor of nonadherence (AOR=2.12, 95% CI=1.93–2.32). Older age and a greater number of medicines in the patient’s regimen were also significantly associated with a greater likelihood of missed doses. Patients with an annual income below $10,000 and those also receiving treatment for a non-HIV comorbid condition were less likely to self-report missed doses in the past 4 days. | | |  | | Model 1 | Model 2 |  |
|---|
 | AOR | 95% CI | AOR | 95% CI |  |
|---|
 | Race | | | | |  |  | White | 1.00 | | 1.00 | |  |  | Black | 2.40 | 1.14–5.08 | 1.80 | 0.51–5.85 |  |  | Gender | | | | |  |  | Female | 1.00 | | 1.00 | |  |  | Male | 0.94 | 0.84–2.01 | 0.97 | 0.80–1.18 |  |  | Age group | | | | |  |  | <40 | 1.00 | | 1.00 | |  |  | 40–49 | 1.29 | 0.64–2.02 | 1.29 | 0.61–2.79 |  |  | ≥50 | 1.48 | 1.09–5.99 | 1.52 | 1.33–1.72 |  |  | Annual income | | | | |  |  | ≥$18,000 | 1.00 | | 1.00 | |  |  | $12,000–$17,999 | 2.26 | 1.20–1.53 | 2.19 | 0.80–6.05 |  |  | $10,000–$11,999 | 1.36 | 0.94–5.47 | 1.10 | 0.64–1.90 |  |  | <$10,000 | 0.42 | 0.19–0.93 | 0.45 | 0.45–0.78 |  |  | Number of HIV medications in regimen | | | | |  |  | 1–2 medicines | 1.00 | | 1.00 | |  |  | ≥3 medicines | 1.24 | 1.17–1.32 | 1.26 | 1.12–1.32 |  |  | Non-HIV comorbid condition | | | | |  |  | No | 1.00 | | 1.00 | |  |  | Yes | 0.74 | 0.66–0.82 | 0.70 | 0.63–0.78 |  |  | Mental illness | | | | |  |  | No prior treatment | 1.00 | | 1.00 | |  |  | Treatment in past 6 months | 1.31 | 0.68–2.47 | 1.11 | 0.66–2.59 |  |  | Literacy level | | | | |  |  | ≥9th grade (adequate) | – | | 1.00 | |  |  | 7th–8th grade (marginal) | | | 1.55 | 0.93–2.45 |  |  | ≤6th grade (low) | | | 2.12 | 1.93–2.32 |  |  | Model fit (C statistic) | 0.68 | | 0.74 | |  | | | |
Discussion  Understanding the reason for pervasive health disparities across race and ethnicity is a major research, practice, and policy goal in the U.S.33, 34 To provide new insights into the pathways that lead to health disparities, patients were recruited from two U.S. regions to examine whether health literacy mediates race disparities in HIV-medication adherence. It was found that African-American patients had a twofold greater likelihood of being nonadherent to their anti-retroviral regimens. Yet consistent with predictions, the inclusion of health literacy reduced the explanatory power of race. In the final model, health literacy, not race, significantly predicted nonadherence. It is believed that this study is the first to examine health literacy as a mediator of race for HIV-medication nonadherence. While the association between race and medication adherence was reduced by 25% once literacy was entered in the model, clearly other factors contributed to racial disparities. In this study alone it was found that treatment-related aspects of regimen complexity and comorbidity independently predicted adherence, as did age and income. Interestingly, patients with the lowest annual household income or those who were contending with a non-HIV comorbid condition were more likely to be adherent than patients with higher household incomes or those without a non-HIV comorbidity. While these relationships were not entirely clear, it is possible that individuals with the least amount of financial resources were being identified by the healthcare system as being at high risk and subsequently intervined upon. This also could be true for those with greater comorbidity, although it is important to note that only medication-taking behaviors were assessed and not health status or actual treatment outcomes. Future studies should seek to investigate in more detail the role of other patient psychosocial characteristics, such as culture and social support, as possible mediators of the now well-established relationships among literacy, health behaviors, and outcomes.6, 35 Certain limitations to the study should be acknowledged. First, adherence could not be assessed using one or a combination of other more objective measures, such as random pill counts, Medical Equipment Management Systems (MEMS) caps, or pharmacokinetic laboratory assessments. Although an existing, validated assessment tool was used to measure HIV-medication adherence,26, 27 through questionnaires patients might have underreported missed doses. However, several recent studies have concluded that self-reported measures, such as the PMAQ, are viable and accurate means to measure adherence.20, 36 Second, these data were derived from a cohort of HIV-infected patients interviewed 5 years ago, and might not reflect directly the experience of those on more current HIV-medication regimens. While more recent advances offer the potential for simplified and less restrictive dosing schedules, adherence still remains a significant challenge for patients with the disease.37, 38 Therefore, it is believed that these findings are relevant to the present day. Despite these limitations, this study is the first to assess the impact of limited health literacy in explaining racial/ethnic differences in medication adherence among a sample of patients from both urban and rural settings. Limited health literacy presents a wide-reaching barrier to disease prevention that, unlike race/ethnicity, is potentially modifiable, which is why this study has important policy implications, particularly with respect to the development of communication strategies to promote HIV-medication adherence that are proven to be effective with patients of all literacy levels. Most health education materials describing medication management and adherence have been written at the high school or college level and may be difficult to understand by individuals with low literacy skills.39 The development of educational strategies that are both appropriate for lower-literacy audiences and culturally sensitive may benefit the large number of patients who are at risk of nonadherence.15, 40, 41, 42, 43 The design of better medication instructions for patients with more-limited literacy, such as improved packaging, labeling, and dispensing practices, is sorely needed.44 Instructional and educational improvements such as these may help decrease the racial disparities in medication adherence; and, ultimately, contribute to reducing disparities in the early development of AIDS and AIDS-related mortality.  Dr. Osborn conducted this research as a National Research Service Award postdoctoral fellow at the Institute for Healthcare Studies, Feinberg School of Medicine at Northwestern University under an institutional award from the Agency for Healthcare Research and Quality. Dr. Wolf is supported by a Career Development Award through the Centers for Disease Control and Prevention (K01 EH000067–01). No financial disclosures were reported by the authors of this paper. References  1. 1Howard DH, Sentell T, Gazmararian JA. Impact of health literacy on socioeconomic and racial differences in health in an elderly population. J Gen Intern Med. 2006;21:857–861.
CrossRef
2. 2Sentell TL, Halpin HA. Importance of adult literacy in understanding health disparities. J Gen Intern Med. 2006;21:862–866.
CrossRef
3. 3Wolf MS, Knight SJ, Lyons EA, et al. Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. Urology. 2006;68:89–93. Abstract | Full Text |
Full-Text PDF (109 KB)
|
CrossRef
4. 4Bowyer NK, Kleinstein RN. Healthy People 2010—vision objectives for the nation. Optometry. 2000;71:569–578. MEDLINE 5. 5Hixon AL, Chapman RW. Healthy People 2010: The role of family physicians in addressing health disparities. Am Fam Physician. 2000;62:1971–1972. 6. 6Institute of Medicine (IOM). Health literacy: a prescription to end confusion. Washington DC: National Academies Press; 2004;. 7. 7Paasche-Orlow MK, Wolf MS. The causal pathways linking health literacy with health outcomes. Am J Health Behav. 2007;. 8. 8Paasche-Orlow MK, Parker RM, Gazmararian JA, Nielsen-Bohlman LT, Rudd RR. The prevalence of limited health literacy. J Gen Intern Med. 2005;20:175–184.
CrossRef
9. 9Sudore RL, Mehta KM, Simonsick EM, et al. Limited literacy in older people and disparities in health and healthcare access. J Am Geriatr Soc. 2006;54:770–776. MEDLINE |
CrossRef
10. 10Kalichman SC, Benotsch E, Suarez T, Catz S, Miller J, Rompa D. Health literacy and health-related knowledge among persons living with HIV/AIDS. Am J Prev Med. 2000;18:325–331. Abstract | Full Text |
Full-Text PDF (188 KB)
|
CrossRef
11. 11Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med. 1999;14:267–273. MEDLINE |
CrossRef
12. 12Miller LG, Liu H, Hays RD, et al. Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis. 2003;36:514–518.
CrossRef
13. 13Wolf MS, Davis TC, Arozullah A, et al. Relation between literacy and HIV treatment knowledge among patients on HAART regimens. AIDS Care. 2005;17:863–873. 14. 14Wolf MS, Davis TC, Cross JT, Marin E, Green K, Bennett CL. Health literacy and patient knowledge in a Southern U.S. HIV clinic. Int J STD AIDS. 2004;15:747–752. MEDLINE |
CrossRef
15. 15Wolf MS, Davis TC, Osborn CY, Skripkauskas S, Bennett CL, Makoul G. Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns. 2007;65:253–260. Abstract | Full Text |
Full-Text PDF (129 KB)
|
CrossRef
16. 16Paasche-Orlow MK, Cheng DM, Palepu A, Meli S, Faber V, Samet JH. Health literacy, antiretroviral adherence, and HIV-RNA suppression: A longitudinal perspective. J Gen Intern Med. 2006;21:835–840.
CrossRef
17. 17McGinnis KA, Fine MJ, Sharma RK, et al. Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data. Am J Public Health. 2003;93:1728–1733. MEDLINE |
CrossRef
18. 18Muir KW, Santiago-Turla C, Stinnett SS, et al. Health literacy and adherence to glaucoma therapy. Am J Ophthalmol. 2006;142:223–226. Abstract | Full Text |
Full-Text PDF (179 KB)
|
CrossRef
19. 19Demmer C. Attitudes toward HIV protease inhibitors and medication adherence in an inner city HIV population. AIDS Patient Care STDs. 2003;17:575–580. MEDLINE 20. 20Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns. 2002;46:93–108. Abstract | Full Text |
Full-Text PDF (165 KB)
|
CrossRef
21. 21Palacio H, Kahn JG, Richards TA, Morin SF. Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep. 2002;117:252–262. MEDLINE |
CrossRef
22. 22Kahn JG, Zhang X, Cross LT, Palacio H, Birkhead GS, Morin SF. Access to and use of HIV antiretroviral therapy: variation by race/ethnicity in two public insurance programs in the U.S.. Public Health Rep. 2002;117:263–272. MEDLINE |
CrossRef
23. 23Morin SF, Sengupta S, Cozen M, et al. Responding to racial and ethnic disparities in use of HIV drugs: analysis of state policies. Public Health Rep. 2002;117:263–272. MEDLINE |
CrossRef
24. 24Siegel K, Karus D, Schrimshaw EW. Racial differences in attitudes toward protease inhibitors among older HIV-infected men. AIDS Care. 2000;12:423–434. 25. 25Gazmararian JA, Kripalani S, Miller MJ, Echt KV, Ren J, Rask K. Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med. 2006;21:1215–1221.
CrossRef
26. 26DeMasi RA, Graham NM, Tolson JM, et al. Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome. Adv Ther. 2001;18:163–173.
CrossRef
27. 27DeMasi RA, Tolson JM, Pham SV, Capuano GA, Fisher RL. Self-reported adherence to HAART and correlation with HIV RNA: Initial results with the patient medication adherence questionnaire. Chicago, Illinois: 6th Conference on Retroviruses and Opportunistic Infections; 1999;. 28. 28Davis TC, Kennen EM, Gazmararian JA, Williams MV. Literacy testing in health care research. In: Schwartzberg JG, VanGeest JB, Wang CC editor. Understanding health literacy: Implications for medicine and public health. Chicago IL: AMA Press; 2004;p. 157–179. 29. 29Davis TC, Long SW, Jackson RH, et al. Rapid estimate of adult literacy in medicine: a shortened screening instrument. Fam Med. 1993;25:391–395. MEDLINE 30. 30Davis TC, Michielutte R, Askov EN, Williams MV, Weiss BD. Practical assessment of adult literacy in health care. Health Educ Behav. 1998;25:613–624. MEDLINE |
CrossRef
31. 31Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173–1182. MEDLINE |
CrossRef
32. 32Lantz PM, Lynch JW, House JS, et al. Socioeconomic disparities in health change in a longitudinal study of U.S. adults: the role of health-risk behaviors. Soc Sci Med. 2001;53:29–40. MEDLINE |
CrossRef
33. 33Williams DR, Jackson PB. Social sources of racial disparities in health. Health Aff. 2005;24:325–334. 34. 34Lurie N, Jung M, Lavizzo-Mourey R. Disparities and quality improvement: federal policy levers. Health Aff. 2005;24:354–364. 35. 35Lee SY, Arozullah AM, Cho YI. Health literacy, social support, and health: a research agenda. Soc Sci Med. 2004;58:1309–1321. MEDLINE |
CrossRef
36. 36Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10:227–245. MEDLINE |
CrossRef
37. 37Gallant JE, DeJesus E, Arribas JR, et al. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. N Engl J Med. 2006;354:251–260.
CrossRef
38. 38Glass TR, De Geest S, Weber R, et al. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2006;41:385–392. MEDLINE |
CrossRef
39. 39Wilson FL, Racine E, Tekieli V, Williams B. Literacy, readability and cultural barriers: critical factors to consider when educating older African Americans about anticoagulation therapy. J Clin Nurs. 2003;12:275–282. MEDLINE |
CrossRef
40. 40Mullins CD, Blatt L, Gbarayor CM, Yang HW, Baquet C. Health disparities: a barrier to high-quality care. Am J Health Syst Pharm. 2005;62:1873–1882. MEDLINE |
CrossRef
41. 41Hussey LC. Minimizing effects of low literacy on medication knowledge and compliance among the elderly. Clin Nurs Res. 1994;3:132–145. MEDLINE |
CrossRef
42. 42Kalichman SC, Cherry J, Cain D. Nurse-delivered antiretroviral treatment adherence intervention for people with low literacy skills and living with HIV/AIDS. J Assoc Nurses AIDS Care. 2005;16:3–15. Abstract | Full Text |
Full-Text PDF (262 KB)
|
CrossRef
43. 43Paasche-Orlow MK, Riekert KA, Bilderback A, et al. Tailored education may reduce health literacy disparities in asthma self-management. Am J Respir Crit Care Med. 2005;172:980–986.
CrossRef
44. 44Wolf MS, Davis TC, Tilson HH, Bass PF, Parker RM. Misunderstanding of prescription drug warning labels among patients with low literacy. Am J Health Syst Pharm. 2006;63:1048–1055. MEDLINE |
CrossRef
a Health Literacy and Learning Program, Institute for Healthcare Studies, Feinberg School of Medicine, Northwestern University, Chicago, Illinois b Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts c Department of Medicine–Pediatrics, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana Address correspondence and reprint requests to: Chandra Y. Osborn, PhD, Institute for Healthcare Studies, Feinberg School of Medicine, Northwestern University, 676 N. St. Clair St., Suite 200, Chicago IL 60611.
The full text of this article is available via AJPM Online at www.ajpm-online.net; 1 unit of Category-1 CME credit is also available, with details on the website. PII: S0749-3797(07)00465-5 doi:10.1016/j.amepre.2007.07.022 © 2007 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved. | |
|